Betrixaban, identified by CAS number 330942-05-7, stands as a significant chemical entity within the realm of anticoagulant therapy. As a highly selective, oral Factor Xa inhibitor, its primary mechanism of action revolves around disrupting the coagulation cascade, thereby reducing the risk of dangerous blood clot formation. For professionals in the pharmaceutical industry, understanding the chemical structure and properties of such compounds is fundamental to their application in drug development and manufacturing.

The chemical formula of Betrixaban, C23H22ClN5O3, and its molecular weight of 451.91 g/mol, provide the foundational data for its synthesis and analysis. Supplied typically as a white powder with a purity of 98%, Betrixaban is utilized by researchers and formulators seeking to create advanced therapeutic agents. Its efficacy in inhibiting Factor Xa, a key enzyme in the blood clotting process, makes it an indispensable component in treatments aimed at preventing venous thromboembolism (VTE) and other clot-related conditions.

The synthesis and supply of Betrixaban require meticulous attention to detail to ensure the highest quality. Manufacturers like NINGBO INNO PHARMCHEM in China are pivotal in providing this pharmaceutical intermediate. Their expertise in chemical synthesis allows for the consistent production of Betrixaban that meets stringent industry standards. For procurement managers, identifying a reliable manufacturer and supplier is crucial for securing a stable and cost-effective supply, enabling uninterrupted research and development pipelines.

The therapeutic application of Betrixaban stems directly from its chemical structure’s ability to bind to and inhibit Factor Xa. This targeted action offers a more predictable anticoagulant effect compared to older medications. When considering where to buy Betrixaban, it is beneficial to engage with suppliers who can offer technical support regarding its handling, storage, and optimal use in formulation. Understanding the price points from various manufacturers can also inform purchasing decisions.

In conclusion, Betrixaban is more than just a chemical compound; it represents a critical advancement in anticoagulant medicine. Its precise chemical properties and role as a Factor Xa inhibitor underscore its importance in pharmaceutical innovation. For professionals aiming to purchase or utilize Betrixaban, partnering with reputable manufacturers and suppliers ensures access to high-quality materials essential for developing the next generation of cardiovascular therapies.